Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

(2014) Takao Koike et al.   Modern Rheumatology

Current prevalence of HTLV-1 in Japan as determined by screening of blood donors

(2011) Masahiro Satake et al.   JOURNAL OF MEDICAL VIROLOGY

Anti-Ro/SSA Antibodies Are an Independent Factor Associated with an Insufficient Response to Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis

(2011) R. MATSUDAIRA et al.   JOURNAL OF RHEUMATOLOGY

Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis

(2010) Karin Hellgren et al.   ARTHRITIS AND RHEUMATISM

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

(2010) M. Iwanaga et al.   BLOOD